XBB subvariants not dominant in China: expert
BEIJING -- The COVID-19 Omicron XBB subvariants have not developed into dominant subvariants in China and will not cause a large-scale epidemic in the country at the current stage, according to an expert with the Chinese Center for Disease Control and Prevention (China CDC).
Chen Cao, research fellow with the National Institute for Viral Disease Control and Prevention under the China CDC, shared the information at a Sunday press conference held by the State Council joint prevention and control mechanism against COVID-19.
Noting the increasing risks of imported cases caused by XBB subvariants, Chen said the antibodies produced by individuals recently infected with BA.5.2 and BF.7 sub-strains will protect them from XBB subvariants to some extent.
In the meantime, the country has further strengthened the monitoring system on novel coronavirus variants and prepared targeted response plans, said Chen.
- China sees recruiting payment increases in major cities
- China unveils latest sci-tech challenges in astronautics
- New Asteraceae species discovered in SW China
- Chinese scientist wins this year's laureate prize
- Beijing condemns US and Japan cross-Strait interference
- Xi calls on Chongqing to write its chapter in Chinese modernization